[Editorial] Immunotherapy: balancing the risks and benefits

Immunotherapy has become one of the most widely used interventions for treating patients with cancer and continues to be a fertile area of research with new targets, drug classes, and combination therapies being discovered regularly. Immunotherapy comprises a wide range of different treatment types that work either with or against the body’s immune system. However, disrupting the immense complexity of human immunity is challenging and can cause life-threatening reactions as well as less obvious long-term consequences.